Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer

Open access
Starczynowski, Daniel T., Lockwood, William W., Deléhouzée, Sophie, Chari, Raj, Wegrzyn, Joanna, Fuller, Megan, Tsao, Ming-Sound, Lam, Stephen, Gazdar, Adi F., Lam, Wan L., Karsan, Aly·2011·Journal of Clinical Investigation

Abstract

Somatic mutations and copy number alterations (as a result of deletion or amplification of large portions of a chromosome) are major drivers of human lung cancers. Detailed analysis of lung cancer-associated chromosomal amplifications could identify novel oncogenes. By performing an integrative cytogenetic and gene expression analysis of non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) cell lines and tumors, we report here the identification of a frequently recurring amplification at chromosome 11 band p13. Within this region, only TNF receptor-associated factor 6 (TRAF6) exhibited concomitant mRNA overexpression and gene amplification in lung cancers. Inhibition of TRAF6 in human lung cancer cell lines suppressed NF-κB activation, anchorage-independent growth, and tumor formation. In these lung cancer cell lines, RAS required TRAF6 for its oncogenic capabilities. Furthermore, TRAF6 overexpression in NIH3T3 cells resulted in NF-κB activation, anchorage-independent growth, and tumor formation. Our findings show that TRAF6 is an oncogene that is important for RAS-mediated oncogenesis and provide a mechanistic explanation for the previously apparent importance of constitutive NF-κB activation in RAS-driven lung cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci58818

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 173

Metadata

Authors
Starczynowski, D. T., Lockwood, W. W., Deléhouzée, S., Chari, R., Wegrzyn, J., Fuller, M., Tsao, M.-S., Lam, S., Gazdar, A. F., Lam, W. L., & Karsan, A.
Venue
Journal of Clinical Investigation
Published
2011-10-03
Volume
121
Issue
10
Pages
4095-4105
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2007251599
Cited by
173
References
5
FWCI
4.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. https://app.cochat.ai/papers/10.1172/jci58818
The paper
Starczynowski, D. T., Lockwood, W. W., Deléhouzée, S., Chari, R., Wegrzyn, J., Fuller, M., Tsao, M.-S., Lam, S., Gazdar, A. F., Lam, W. L., & Karsan, A. (2011). TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci58818

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.